Lebenthal Global Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Lebenthal Global Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$742K	Buy	1,510 +409	+37%	+$222K	0.11%	137
2025 Q4	$638K	Buy	+1,101	New	+$623K	0.1%	132
2023 Q3	–	Sell	-964	Closed	-$503K	–	131
2023 Q2	$503K	Buy	964 +63	+7%	+$34K	0.15%	73
2023 Q1	$519K	Sell	901 -21	-2%	-$11.8K	0.16%	70
2022 Q4	$508K	Buy	922 +85	+10%	+$45K	0.17%	68
2022 Q3	$424K	Sell	837 -42	-5%	-$23.5K	0.19%	66
2022 Q2	$477K	Buy	879 +26	+3%	+$14.3K	0.23%	70
2022 Q1	$503K	Buy	853 +101	+13%	+$58K	0.21%	82
2021 Q4	$501K	Buy	+752	New	+$470K	0.2%	77

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lebenthal Global Advisors's TMO Position: Q1 2026 in Review

Lebenthal Global Advisors increased its Thermo Fisher Scientific (TMO) stake by 37% in Q1 2026, buying an estimated $222K and bringing the position to 1,510 shares worth $742K. The position accounts for 0.11% of the portfolio, ranked #137.

Lebenthal Global Advisors first reported a position in TMO in Q4 2021 and has held it in 9 quarters since. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Lebenthal Global Advisors held 1,510 shares of Thermo Fisher Scientific worth $742K as of Q1 2026.
Lebenthal Global Advisors bought 409 Thermo Fisher Scientific shares in Q1 2026, an estimated $222K.
Thermo Fisher Scientific made up 0.11% of Lebenthal Global Advisors's portfolio in Q1 2026, its #137 holding.
Lebenthal Global Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 9 quarters since.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Lebenthal Global Advisors's 13F filing for Q1 2026, filed 14 May 2026.